Life Science ApS: Financial statements 2023
CVR: 38453726
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Life Science ApS (CVR 38453726) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -245 and a net result of DKK -245 compared with DKK -744 the year before. Equity in the 2023 report amounted to DKK 14,617. The solvency ratio was 4.7%.
- Gross Profit
- DKK -245
- Profit/Loss
- DKK -245
- Equity
- DKK 14,617
- Total Assets
- DKK 309,165
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -245 | -245 | 15 t. | - |
| 2022 | - | -733 | -744 | 15 t. | - |
| 2021 | - | -2 t. | -2 t. | 16 t. | - |
| 2020 | - | 0 | -3 | -21 t. | - |
| 2019 | - | -843 | -843 | -21 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Life Science ApS has published its annual report for 2022. Gross profit came to DKK -733, and the net result was DKK -744.
About Life Science ApS
Life Science ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Life Science IVS and FluoGuide IVS. The management consists of Andreas Kjær and Morten Albrechtsen. The company is owned by Andreas Kjær and WEXOTEC ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,459 and a net result of DKK -11,456 compared with DKK -822 the year before. Equity in the 2025 report amounted to DKK 151,200.